Replies to post #3201 on InMed Pharmaceuticals Inc (INM)

[lesgetrich]

There are 90+ cannabinoids in the cannabis plant. From what I read, it seems they aren't producing any of them. They're making synthetic molecules that they say act like cannabinoids which they call cannabosides.

Vitality Biopharma Inc. (OTCMKTS:VBIO) biosynthesis technology uses small molecule glycosylation to create new compounds known as cannabinoid glycosides or cannabinoids. The company has reportedly improved the technology 15-fold...

...The share price target according to the firm is based on the company’s developments on new class of cannabinoid pharmaceuticals called cannabosides.

The products produced by InMed's biosynthesis are reportedly identical to the cannabinoids found in the plant. Vitality's products are not.